Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imfinzi, tremelimumab combo flunks SCLC trial

pharmatimesMarch 19, 2020

Tag: Imfinzi , tremelimumab , SCLC

PharmaSources Customer Service